Buy & Sell SYSCO Corporation (SYY) – SYSCO Corporation Price Today
Aura AI Summary
Key Stats
- $38.66BMarket Cap
- Consumer StaplesSector
- -15.28%3M Drawdown
- $52.14BEnterprise Value
- 2.72%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 74 daysTypical Hold Time
SYSCO Corporation (SYY) is currently valued at a market capitalization of $38.66B, with an enterprise value of $52.14B. Over the past 52 weeks, SYSCO Corporation has traded between a low of $69.3 and a high of $91.16, highlighting its annual price range. Over the past three months, SYSCO Corporation has recorded a drawdown of -15.28%, reflecting recent price volatility. SYSCO Corporation offers a dividend yield of 2.72%, with the most recent dividend of $0.54 paid on 02 Apr 26. On average, investors hold SYSCO Corporation for approximately 74 days, indicating typical investor behavior on the platform.
About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Most Recent News
Complex small molecules reshape drug R&D, demanding integrated discovery to manufacturing solutions.
WuXi AppTec highlights how the increasing structural complexity of small molecules, such as targeted protein degraders and covalent inhibitors, is transforming drug research and development. These new molecules require advanced, integrated approaches...
Axsome starts Phase 3 trial of solriamfetol for ADHD in adolescents, aiming to improve treatment options.
Axsome Therapeutics has initiated the FOCUS-3 Phase 3 clinical trial to evaluate solriamfetol as a treatment for adolescents aged 12 to under 18 with ADHD. This randomized, double-blind, placebo-controlled study will enroll about 468 patients to asse...
SoundHound AI's COO sells 65,000 shares, signaling insider stock movement.
SoundHound AI's Chief Operating Officer has sold 65,000 shares of the company's stock. This insider sale could indicate personal financial decisions or a strategic move related to the company's outlook. Investors often watch such transactions closely...
